These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 560634)
1. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat. Pycock C Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Srinivasan J; Schmidt WJ Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465 [TBL] [Abstract][Full Text] [Related]
3. Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions, Iwamoto ET; Loh HH; Way EL Eur J Pharmacol; 1976 Jun; 37(2):339-56. PubMed ID: 986305 [TBL] [Abstract][Full Text] [Related]
4. Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons. Braestrup C Psychopharmacology (Berl); 1977 Jan; 51(2):199-204. PubMed ID: 402674 [TBL] [Abstract][Full Text] [Related]
5. The interaction of clonidine with dopamine-dependent behaviour in rodents. Pycock CJ; Jenner PG; Marsden CD Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529 [TBL] [Abstract][Full Text] [Related]
6. Noradrenergic influences on catalepsy. Mason ST; Roberts DC; Fibiger HC Psychopharmacology (Berl); 1978 Dec; 60(1):53-7. PubMed ID: 104346 [TBL] [Abstract][Full Text] [Related]
7. Papaverine, drug-induced stereotypy and catalepsy and biogenic amines in the brain of the rat. Kostowski W; Gajewska S; Bidzinski A; Hauptman M Pharmacol Biochem Behav; 1976 Jul; 5(1):15-7. PubMed ID: 1033561 [TBL] [Abstract][Full Text] [Related]
8. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine. Nahorski SR Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249 [TBL] [Abstract][Full Text] [Related]
9. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Costall B; Naylor RJ; Pycock C Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine. Carter CJ; Pycock CJ Pharmacol Biochem Behav; 1979 Apr; 10(4):475-80. PubMed ID: 572550 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin on the central action of dopamine. Braszko J; Wiśniewski K Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924 [TBL] [Abstract][Full Text] [Related]
12. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions. Iwamoto ET; Loh HH; Way EL J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346 [TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system. Kania BF Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616 [TBL] [Abstract][Full Text] [Related]
14. Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats. Pycock CJ; Donaldson IM; Marsden CD Brain Res; 1975 Oct; 97(2):317-29. PubMed ID: 1175049 [TBL] [Abstract][Full Text] [Related]
15. Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol. Kataoka Y; Ohta H; Fujiwara M; Oishi R; Ueki S Neuropharmacology; 1987 Jan; 26(1):55-60. PubMed ID: 3031535 [TBL] [Abstract][Full Text] [Related]
16. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Castall B; Marsden CD; Naylor RJ; Pycock CJ Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267 [TBL] [Abstract][Full Text] [Related]
17. Effects of dihydroergotoxine on some dopamine-related behaviors in rats. Flório JC; Palermo-Neto J Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797 [TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Srinivasan J; Schmidt WJ Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435 [TBL] [Abstract][Full Text] [Related]
19. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway. Reavill C; Leigh N; Jenner P; Marsden CD Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328 [TBL] [Abstract][Full Text] [Related]
20. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus. Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]